Amedisys, Inc. (AMED) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Amedisys, Inc., with annual and quarterly history.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 68.71x | -316.87x | 22.90x | 25.27x | 52.02x | 42.30x |
| P/B Ratio | 2.62x | 2.90x | 2.58x | 5.67x | 11.80x | 8.38x |
| P/S Ratio | 1.26x | 1.38x | 1.22x | 2.39x | 4.61x | 2.74x |
| Profitability | ||||||
| Gross Margin | 43.3% | 44.3% | 43.3% | 44.3% | 42.8% | 41.2% |
| Operating Margin | 4.0% | 7.0% | 8.1% | 11.4% | 10.6% | 9.1% |
| Net Margin | 1.8% | -0.4% | 5.3% | 9.4% | 8.9% | 6.5% |
| EBITDA Margin | 3.1% | 9.7% | 9.3% | 14.5% | 12.1% | 10.4% |
| Liquidity | ||||||
| Current Ratio | 1.23x | 1.05x | 1.09x | 0.95x | 0.79x | 1.07x |
| Quick Ratio | 1.23x | 1.05x | 1.09x | 0.95x | 0.77x | 1.07x |
| Leverage | ||||||
| Debt/Equity | 0.41x | 0.46x | 0.51x | 0.59x | 0.38x | 0.51x |
YoY = year-over-year change. Source: FMP..